Short Video Statements

Latest video

References:

• Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis, ESMO Open. 2020; 5: e000947
• Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19), Eur J Cancer 2020; 141: 62-81
• COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study, Lancet Oncol 2020; 21: 914–22
• COVID-19 in patients with lung cancer, Ann Oncol 2020; 10:1386-1396

---

References:

• Pulmonary alveolar proteinosis, Nature Reviews Disease Primers 2019; 5: 16
• Inhaled GM-CSF for Pulmonary Alveolar Proteinosis, N Engl J Med 2019; 381:923-932
• Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis, N Engl J Med 2020; 383:1635-1644

---

References:

• ESR/ERS statement paper on lung cancer srcreening
• ESR/ERS white paper on lung cancer screening
• European position statement on lung cancer screening

---

References:

• Mepolizumab or placebo for Eosinophilic Granulomatosis with Polynagiitis
• Rituximab as induction therapy in EGPA refractory to conventional immunosuppressive treatment: A 36 month follow up analysis

---

References:

• Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
• Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
• Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

---

COVID-19